{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Hands-on tutorial on Environmental health risk assessment\n",
    "\n",
    "- Four steps\n",
    "- Hazard identification\n",
    "- Exposure assessment\n",
    "- Dose response assessment\n",
    "- Risk characterisation\n",
    "\n",
    "## Hazard identification\n",
    "\n",
    "## Dose-response\n",
    "\n",
    "## Dose\n",
    "- Amt of substance administered at one time\n",
    "- Absorbed dose: enters the body through skin, eyes, lungs, digestive tract --> taken up by organs --> internal dose\n",
    "- \n",
    "## Expposure\n",
    "- Concentration of the substance in the environment\n",
    "- Amount of substance taken inside the body\n",
    "- Duration and frequency of the individual events\n",
    "- mg/L (liquid)\n",
    "- mg/G (solids)\n",
    "- mg/m3 (air)\n",
    "\n",
    "## Dose response\n",
    "- Higher the dose, more severe the response\n",
    "- Causality - chemical caused the observed effects\n",
    "- Threshold effect - the lowest dose at which an induced effect occurs\n",
    "- Slope - Rate at which injury builds up\n",
    "\n",
    "## Threshold for toxic effects\n",
    "- Point where body's ability to detoxify has been exceeded\n",
    "- Most organs have a reserve capacity\n",
    "\n",
    "## Dose Estimates\n",
    "- LD50 - acute toxicity\n",
    "- Maxium dose at which 50% of the group of organisms would be expected to die\n",
    "- \n",
    "\n",
    "## Hazard identification\n",
    "- Whether a chemical poses human health risk\n",
    "- Epidemiology\n",
    "- Animal testing\n",
    "- in vitro\n",
    "- QSAR (quantitative structure activity)\n",
    "- Adverse outcome pathways\n",
    "- High dose studies in lab animals -> in vitro methods using human-relevant cellular signalling pathways\n",
    "- Lung on a chip\n",
    "\n",
    "## Hazard identification 2\n",
    "- Acute toxicity- LD50 (obsolete)\n",
    "- There is no formal procedure\n",
    "- Assess the different types of health effects from the toxicity databases\n",
    "\n",
    "## Dose response assessment\n",
    "- Quantitates\n",
    "- Carcinogenic\n",
    "- Non-carcinogenic\n",
    "\n",
    "## Carcinogenic\n",
    "- No threshold\n",
    "\n",
    "## Method of dose response assessment\n",
    "- Step 1\n",
    "- Perform qualitative evaluation of \n",
    "- All epidemiology studies\n",
    "- All animal bioassay data\n",
    "- All biological activity, i.e. mutagenicity\n",
    "- Classify as definite, probable, or possible carcinogen\n",
    "\n",
    "## Step 2 of dose response asssessment for carcinogens\n",
    "- If the substances are probable or definite\n",
    "- Quantitate the risk using mathematical models\n",
    "- Extrapolate from high experimental doses to low environmental doses\n",
    "\n",
    "## Classification of a carcinogen\n",
    "- EPA classification\n",
    "- WHO classification\n",
    "\n",
    "## EPA classification\n",
    "- Carcinogenic to humans (causal evidence from human data)\n",
    "- LIkely to be carcinogenic (causal evidence from animal bioassay but no supportive evidence from human data)\n",
    "- Suggestive evidence of carcinogenic potential (limited animal evidence but no human evidence)\n",
    "- Inadequate information (data insufficient to refute/confirm)\n",
    "- Not likely to be\n",
    "\n",
    "## Linear carcinogens\n",
    "- Estimation of risk is based on \n",
    "- unit risk estimate for inhalation\n",
    "- carcinogenic potency slope for ingestion\n",
    "\n",
    "## What is URE\n",
    "- URE = upper bound excess lifetime risk\n",
    "- URE results from continuous exposure to agent over lifetime at a concentration of 1 microg/cumm in air\n",
    "- One lifetime = 70 years\n",
    "- if URE = 1.5 * 10^-6 microg/cu.mm, THEN:\n",
    "- No more than 1.5 EXCESS tumours are expected to develop \n",
    "- per 1000000 people if they were exposed ALL day, EVERY day\n",
    "- for a LIFETIME to a concentration of 1 microgram/cu.mm of air\n",
    "- Upper bound of a risk\n",
    "- Actual risk may be lower\n",
    "\n",
    "## What is CPS\n",
    "- Upper bound of a 95% Confidence\n",
    "- increased cancer risk from a lifetime oral ingestion\n",
    "- proportion of a population affected per mg/Kg/day\n",
    "- assume 70 kg body weight\n",
    "- Extrapolate from the low dose region of the dose-response relationship\n",
    "- Exposures corresponding to risks < 1 in 100\n",
    "\n",
    "## IARC (WHO) Classification\n",
    "- Group 1: Carcinogenic to humans\n",
    "- Group 2A: Probably carcinogenic to humans\n",
    "- Group 2B: Possibly carcinogenic to humans\n",
    "- Group 3: Not classifiable as carcinoge ic\n",
    "\n",
    "## Preamble to monographs (pp 31)\n",
    "- Sufficient evidence: causal association between agent and human cancer established\n",
    "- Limited evidence: causal interpretation is credible but cannot rule out chance, bias, and confounding with confidence\n",
    "- Inadequate evidence: poor quality, consistency, statistical precision, no data for humans, \n",
    "- Lack of evidence: high quality consistent studies showing No positive association\n",
    "\n",
    "## Qualitative evaluation of risk\n",
    "\n",
    "## Quantitative evaluation of cancer risk\n",
    "- If it is definite or probable carcinogen, then do a quantitative risk assessment\n",
    "- Cancer slope parameter\n",
    "- Upper bound \n",
    "## Cancer slope parameter\n",
    "- Toxicity value that:\n",
    "- defines relationship between dose and response\n",
    "- Upper bound estimate\n",
    "- Used to estimate the Probability that an individual will develop cancer if exposed to a chemical for a lifetime of 70 years\n",
    "- Unit of slope factor is mg/Kg/day\n",
    "\n",
    "## Linear multistage model\n",
    "![models](models.png)\n",
    "\n",
    "## Non-carcinogenic effect\n",
    "- Dose thresholds\n",
    "- Lowest dose / safety factors = Margin of safety\n",
    "- Minimal risk levels\n",
    "- MRL: daily exposure to a substance S\n",
    "- that exposure will be without appreciable risk of adverse effects\n",
    "- the exposure must be over a specified period\n",
    "- 0-14 days for acute effects\n",
    "- 15-364 days for intermediate effets\n",
    "- >= 365 days for long term or chronic effects\n",
    "- Uncertainty factors are 10, 1, or 3\n",
    "- Use LOAEL\n",
    "\n",
    "## Critical effect\n",
    "- Select an effect that is critical\n",
    "- If the critical effect is prevented, then the health effect will not result\n",
    "\n",
    "## Animal studies\n",
    "- Done to augment human study data\n",
    "- Can control the number and composition of test subjects\n",
    "- Can control the dosage\n",
    "- Usually the dosage is higher than what is experienced with humans\n",
    "- The dosage must be extrapolated to humans\n",
    "- This is where we introduce uncertainties\n",
    "\n",
    "## Concepts of dose-response calculations\n",
    "\n",
    "## Non-linear dose-response assessment\n",
    "- Threshold hypothesis\n",
    "- Organisms (read: humans) can tolerate a range of exposures starting from 0 to some value\n",
    "- Threshold of toxicity is the dosage where the effects START to happen\n",
    "- Focus on the most sensitive members of the community\n",
    "- Aim to keep the exposure BELOW threshold value\n",
    "\n",
    "## Non-linear association\n",
    "- mode of action suggests toxicity has a threshold\n",
    "- Below the threshold no toxicity will be manifest\n",
    "- above the threshold, toxicity\n",
    "- NOAEL: highest exposure at which NO biologically significant inreases in the severity of adverse effect\n",
    "- if NOAEL is NOT possible, then LOAEL\n",
    "- What is the lowest dose at which biologically meaningful significant toxic effect gets manifest\n",
    "\n",
    "## Reference dose\n",
    "- Oral or dermal\n",
    "- f(NOAEL | LOAEL, UF)\n",
    "- Rfd = NOAEL / UF\n",
    "- If data comes from human studies, UF = 10\n",
    "- If data comes from animals, then humans, UF = 10 * 10\n",
    "- If instead of NOAEL, LOAELs used, add 10 fold\n",
    "- Rfd = LOAEL / 10 * 10 * 10 OR LOAEL = 10 * 10\n",
    "- Alternatively, Rfd = LOAEL / sqrt(10) for human studies\n",
    "- OR, Rfd = LOAEL / sqrt(10) * sqrt(10) = LOAEL / 10\n",
    "- Estimate of a DAILY oral exposure to human that is likely to be WITHOUT an appreciable risk of toxic effect over a lifetime \n",
    "\n",
    "## Reference dose\n",
    "- Expressed in mg/Kg/day\n",
    "\n",
    "## Linear dose-response association\n",
    "- Toxicity does not have a threshold\n",
    "- 0 threshold\n",
    "- Do not use UFs\n",
    "- From the origin, (0,0), draw a line to the (dose, response) point where toxic effects manifest\n",
    "- The point where toxic effects manifest is called departure point\n",
    "- Estimate the slope of the line: slope factor\n",
    "- For cancer use the slope to estimate excessive cancer risk\n",
    "- Probability that a person will have cancer over a lifetime resulting from exposure \n",
    "- Cancer risk = slope factor * Exposure\n",
    "\n",
    "## Exposure assessment\n",
    "\n",
    "## Risk characterisation\n",
    "\n",
    "## IPCS framework\n",
    "- Literature search\n",
    "- Data search from international agencies\n",
    "- \n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Hazard identification resources\n",
    "- https://ntpsearch.niehs.nih.gov/?query=nitrogen&e=False&suffixes=false\n",
    "- https://toxnet.nlm.nih.gov/\n",
    "- https://www.youtube.com/channel/UCeP-bYPc1CRD3Ieaqrl-ysg\n",
    "- [Table of dose-response values](https://www.epa.gov/sites/production/files/2014-05/documents/table1.pdf)\n",
    "- [Assessment of EPA carcinogenic risk](https://www.epa.gov/fera/risk-assessment-carcinogenic-effects)\n",
    "- [Preamble](https://monographs.iarc.fr/wp-content/uploads/2019/07/Preamble-2019.pdf)\n",
    "- [Llist of classifications](https://monographs.iarc.fr/list-of-classifications)\n",
    "- [List of cancer causing agents by organ](https://monographs.iarc.fr/wp-content/uploads/2019/07/Classifications_by_cancer_site.pdf)\n",
    "- [Discussion document](https://monographs.iarc.fr/wp-content/uploads/2019/07/Cogliano_2011_JNCI_Preventable_Exposures.pdf)\n",
    "- [List of monograph](https://monographs.iarc.fr/monographs-available/)\n",
    "- [Updated EPA guidelines](https://www.epa.gov/sites/production/files/2013-09/documents/cancer_guidelines_final_3-25-05.pdf)\n",
    "- [Document for reference dose calculations](https://www.epa.gov/sites/production/files/2014-12/documents/rfd-final.pdf)\n",
    "- [EPA risk assessment tutorials](https://www.epa.gov/risk/conducting-human-health-risk-assessment#tab-3)\n",
    "- [IPCA risk assessment toolkit](https://apps.who.int/iris/bitstream/handle/10665/44458/9789241548076_eng.pdf;jsessionid=16DE6A8C8B73CA1C93D6512131F1B91B?sequence=1)\n",
    "- [Environmental health criteria](https://www.who.int/ipcs/publications/ehc/methodology_alphabetical/en/)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.051100000000000007"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "conc = 0.07\n",
    "micro2milli = conc/1000\n",
    "waterld = 2\n",
    "total_days = 70 * 365\n",
    "bw = 70\n",
    "waterld * total_days * micro2milli / bw"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.07"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "70 * 1000 / 1000000"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "10.000000000000002"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "(10 ** 0.5) * (10 ** 0.5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
